Tag: Ozempic
Novo Nordisk Slips on Q2 Miss and Copycat Drug Pressures
Weak Earnings Follow Downward Guidance Revision Novo Nordisk shares traded lower in premarket action Wednesday after the pharmaceutical company missed Wall Street expectations on both [more…]
Ozempic’s Ripple Effect: Slimming Waists, Swelling Markets
In a recent gathering that drew crowds to a Philadelphia ballroom, the American Heart Association meeting unveiled striking results about Wegovy, a novel weight-loss drug. [more…]
